A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma.
- DOI
- 10.1007/s11060-021-03763-1
- Published
- 2021 Jun
- Container
- Journal of neuro-oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s11060-021-03763-1,
title = {A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma.},
author = {El-Khouly FE and Veldhuijzen van Zanten SEM and Jansen MHA and Bakker DP and Sanchez Aliaga E and Hendrikse NH and Vandertop WP and van Vuurden DG and Kaspers GJL},
year = {2021},
journal = {Journal of neuro-oncology},
doi = {10.1007/s11060-021-03763-1},
url = {https://doi.org/10.1007/s11060-021-03763-1}
}RIS
TY - JOUR TI - A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma. AU - El-Khouly FE AU - Veldhuijzen van Zanten SEM AU - Jansen MHA AU - Bakker DP AU - Sanchez Aliaga E AU - Hendrikse NH AU - Vandertop WP AU - van Vuurden DG AU - Kaspers GJL PY - 2021 JO - Journal of neuro-oncology DO - 10.1007/s11060-021-03763-1 UR - https://doi.org/10.1007/s11060-021-03763-1 ER -
APA
FE, E., SEM, V. V. Z., MHA, J., DP, B., E, S. A., NH, H., WP, V., DG, V. V., & GJL, K. (2021). A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma.. Journal of neuro-oncology. https://doi.org/10.1007/s11060-021-03763-1
Source records
- pubmed · retrieved 2026-09-25T22:15:06.982Z